✦ LIBER ✦

Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

✍ Scribed by David Goldstein; M. Corona Gainford; Chris Brown; Niall Tebbutt; Stephen P. Ackland; Guy van Hazel; Michael Jefford; Ehtesham Abdi; Sid Selva-Nayagam; Val Gebski; Danielle Miller; Jenny Shannon

Publisher: Springer
Year: 2010
Tongue: English
Weight: 268 KB
Volume: 67
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1351-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of gemcitabine combined w

Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

✍ Jeeyun Lee; Tae-You Kim; Myung Ah Lee; Myung Ju Ahn; Hoon-Kyo Kim; Ho Yeong Lim; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 246 KB

Fixed dose-rate infusion of gemcitabine

Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas

✍ J. Feliu; J. García Sáenz; A. Rodríguez Jaráiz; C. Castañón; M. Cruz; E. Fonseca 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 225 KB

Capecitabine combined with gemcitabine (

Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma

✍ Jae Yong Cho; Yong Han Paik; Yoon Soo Chang; Se Joon Lee; Dong-Ki Lee; Si Young 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

A phase II study of gemcitabine in combi

A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer

✍ Hyun Jung Kim; Nam Su Lee; Sang-Cheol Lee; Sang Byung Bae; Chan Kyu Kim; Young G 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 347 KB

Dose-escalation study of fixed-dose rate

Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies

✍ Steven Attia; Sherry Morgan-Meadows; Kyle D. Holen; Howard H. Bailey; Jens C. Ei 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 380 KB

Pharmacokinetic study of gemcitabine, gi

Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer

✍ Orazio Caffo; Stefania Fallani; Elena Marangon; Stefania Nobili; Maria Iris Cass 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 171 KB